Spina bifida is a birth defect characterized by incomplete closure of the embryonic neural tube.
Genetic factors as well as environmental factors have been observed to influence risks for spina bifida. Few studies have investigated possible gene-environment interactions that could contribute to spina bifida risk. The aim of this study is to examine the interaction between gene variants in biotransformation enzyme pathways and ambient air pollution exposures and risk of spina bifida.
We evaluated the role of air pollution exposure during pregnancy and gene variants of biotransformation enzymes from bloodspots and buccal cells in a California population-based case-control (86 cases of spina bifida and 208 non-malformed controls) study. We considered race/ethnicity and folic acid vitamin use as potential effect modifiers and adjusted for those factors and smoking. We observed gene-environment interactions between each of the five pollutants and several gene variants: NO (ABCC2), NO 2 (ABCC2, SLC01B1), PM 10 (ABCC2, CYP1A1, CYP2B6, CYP2C19, CYP2D6, NAT2, SLC01B1, SLC01B3), PM 2.5 (CYP1A1 and CYP1A2). These analyses show positive interactions between air pollution exposure during early pregnancy and gene variants associated with metabolizing enzymes. These exploratory results suggest that some individuals based on their genetic background may be more susceptible to the adverse effects of pollution.
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| I N TR ODU C TI ON
Spina bifida is a human structural birth defect characterized by incomplete closure of the embryonic neural tube and is the more frequently observed phenotype among its broader group known as neural tube defects. Folic acid fortification of the food supply has been associated with reductions of neural tube defects by approximately 20% in the United States (Honein, Paulozzi, Mathews, Erickson, & Wong, 2001 ).
Additionally, other environmental risk factors have been hypothesized to contribute to neural tube defect risk; several studies have examined the role of air pollution (Girguis et al., 2016; Lupo et al., 2011; Padula et al., 2013) . The results across studies are not consistent, though several studies do find increased risk associations between early prenatal exposure to air pollution and neural tube defects (Lupo et al., 2011) , including our previous study, which found an association between carbon monoxide (CO) and nitrogen dioxide (NO 2 ) and increased risk of spina bifida (Padula et al., 2013) .
It is thought that most structural birth defects are caused by a complex combination of genetic and environmental factors that interact to interfere with morphogenetic processes; however, few studies have examined the interaction of genetic and environmental factors. and one with occupational chemical exposures (Shaw, Nelson, Iovannisci, Finnell, & Lammer, 2003) . Fewer such gene-environment interaction studies have been conducted specifically on spina bifida with most focused on folate transport or metabolism.
The current study examines the interaction between gene variants in biotransformation enzyme pathways, enzyme pathways known to mediate detoxification of xenobiotic exposures, and ambient air pollution exposures and risk of spina bifida risk in a population-based casecontrol study the San Joaquin Valley of California.
| M E TH ODS

| Study population
The California Center of the National Birth Defects Prevention Study (Reefhuis et al., 2015; Yoon et al., 2001 ) is a collaborative partnership between Stanford University and the California Birth Defects Monitoring Program in the Department of Public Health. Since 1997, the Center has collected data from women residing in eight counties (San Joaquin, Stanislaus, Merced, Madera, Fresno, Kings, Tulare, and Kern) in the San Joaquin Valley. The California Birth Defects Monitoring Program is a surveillance program that is population-based (Croen, Shaw, Jensvold, & Harris, 1991) . To identify cases with birth defects, data collection staff visit all hospitals with obstetric or pediatric services, cytogenetic laboratories, and all clinical genetics prenatal and postnatal outpatient services.
Cases in the current analysis included infants or fetuses with spina bifida as confirmed by clinical, surgical, or autopsy reports. Cases recognized or strongly suspected to have single-gene conditions or chromosomal abnormalities or with identifiable syndromes were ineligible (Rasmussen et al., 2003) , given their presumed distinct underlying etiology. Controls included non-malformed live-born infants randomly selected from birth hospitals to represent the population from which the cases arose. Maternal interviews were conducted by using a standardized, computer-based questionnaire, primarily by telephone, in English or Spanish, between 6 weeks and 24 months after the infant's estimated date of delivery. Estimated date of conception was derived by subtracting 266 days from the expected date of delivery. The expected date of delivery was based on self-report; if unknown, it was estimated from information in the medical records (<2% of participants).
Interviews were conducted with mothers of 74% of eligible cases and 69% of controls. The present analysis includes 86 cases of spina bifida and 208 controls with estimated delivery dates between October 1, 1997, and December 31, 2006. Mothers with diabetes (type 1 or type 2) prior to gestation were excluded. Mothers reported a full residential history from 3 months before conception through delivery, including start and stop dates for each residence. The Centers for Disease Control and Prevention geocoded the addresses by using Centrus Desktop (Pitney Bowes, Inc., Stamford, CT), which combines reference street networks from Tele Atlas B. V. ( 0 s-Hertogenbosch, the Netherlands) and U.S. Postal Service data. Geocodes were available for the addresses of 95% of cases (n 5 151) and 93% of controls (n 5 900).
Out of 138 cases and 849 controls exposed to any pollutants during the first 2 months of pregnancy, we identified 101 and 508 with blood spots or buccal samples available at lab. Out of 508 controls, we randomly selected 250 samples for further genotyping. We finally were able to genotype 96 cases and 230 controls due to missing samples.
The present analysis includes 86 cases of spina bifida and 208 controls with call rate 89%.
| Genotyping analyses
For genetic experiments, DNA was derived from newborn bloodspots (infants only) or buccal samples (infant and mother of infants). A specific method to extract DNA was developed in the Lammer lab and has been used for numerous genotyping preparations in our molecular epidemiology work [e.g., (Shaw et al., 2003) ]. We used this method to extract genomic (not amplified) DNA (gDNA) of sufficient quality and quantity from these precious bloodspots to provide excellent performance with Illumina GWAS platforms (2.5m). Genomic DNA was extracted from buccal brushes using an established protocol (NaOH extraction (Richards et al., 1993) Although mainly known as "drug metabolizing enzymes," such biotransformation enzymes are involved in metabolizing both endogenous compounds and myriad xenobiotic chemicals (Nebert, 1997) . For xenobiotics, these enzymes are important for detoxifying both parent compounds and reactive intermediate chemicals that may be teratogenic.
Genetic variants have been described for a number of these metabolizing enzymes. For this project, we chose candidate genes whose variants are known to have altered enzyme activity or inducibility by xenobiotic compounds likely to be encountered in a pregnant woman's environment. These genes include, for example, the acetyl-N-transferases (NATs, NAT1 1088, NAT11095, and NAT2), cytochrome P450 (CYP1A1, CYP1A2, CYP2A6, YPC2B6, CYP2C19, CYP2C8, CYP2C9, CYP2D6, CYP3A4, CYP3A5), and the glutathione S-transferases (GSTM1 and GSTT1). The full list of gene variants is shown in Table 2 . We also included other relevant genes like nitric oxide synthase (NOS3), which regulates nitric oxide production and has been associated with orofacial clefts and maternal smoking (Shaw et al., 2005 
| Statistical analyses
Risk for spina bifida associated with each infant gene variant was calculated for both the homozygotes and the heterozygotes, with homozygous wildtypes as the referent. For each gene variant, the wildtype/ reference genotype was defined as the homozygous genotype with the most frequent allele among controls. Risks were estimated as ORs with 95% confidence intervals (CIs) by logistic regression using SAS software (version 9.4, SAS Institute, Cary, NC). Regression analyses were stratified by maternal race/ethnicity (Hispanic and non-Hispanic white).
Wald chi-square tests were calculated for the interaction terms to determine if the subgroups were statistically different.
Regression analyses were stratified by air pollution exposure (highest tertile versus lower two tertiles). For these analyses, homozygous variants and heterozygotes were combined and compared to homozygous wildtypes as the referent. Wald chi-square tests were calculated for the interaction terms to determine if the subgroups were statistically different. ORs were calculated for 104 genotypes and 5 pollutants for a total of 520 comparisons for the gene-environment interaction
analyses. These models were adjusted for maternal race/ethnicity, vitamin use (folic acid containing in 1 month before conception and first 2 months of pregnancy), BMI (continuous), and smoking (active and/or passive versus none). These analyses were additionally stratified by maternal use of vitamins containing folic acid.
We conducted a sensitivity analysis on the maternal genotypes to determine if the results were consistent (N 5 37).
| RE S U L TS
The study population included 86 spina bifida cases and 208 controls from the San Joaquin Valley of California. The demographic characteristics of cases and controls are presented in Table 1 . Case mothers were slightly less likely to have competed >12 years of education or to have used multivitamin supplements and slightly more likely to be foreign-born Hispanic and to be exposed to passive cigarette smoke.
Case mothers were more likely to be overweight or obese and control mothers had a more even distribution across age categories. PM 2.5 and UGT2B15 (rs1902023); NO and CYP2C19 (rs12248560)).
No statistically significant interactions were observed between variants and CO and risk of spina bifida.
The interaction of PM 10 and several variants of CYP, NAT, and SLC genes resulted in increased odds of spina bifida (Table 6 ). The var-
(rs4149117), and ORs ranged from 2.4 to 4.0. Similar to PM 10 , high exposure to PM 2.5 and several variants of CYP and SLC genes were associated with increased odds of spina bifida (Table 7) . The statistically significant ORs ranged from 3.2 to 7.4 for the following gene variants, 
| D I SCUSSION
In our previous study of air pollution exposures during the first 2 months of pregnancy, we found associations between elevated levels of CO and NO 2 and risk of spina bifida (OR CO 5 2.00, 95% CI: 1.06, 3.75; OR NO2 5 1.73, 95% CI: 1.01, 2.97) (Padula et al., 2013) . Our current study extends those findings and demonstrates a geneenvironment interaction between each of the five pollutants and several gene variants: NO (ABCC2), NO 2 (ABCC2, SLC01B1), PM 10 (ABCC2, CYP1A1, CYP2B6, CYP2C19, CYP2D6, NAT2, SLC01B1, SLC01B3), PM 2.5 (CYP1A1 and CYP1A2). These gene pathways are involved in metabolizing both endogenous compounds and myriad xenobiotic chemicals (Nebert, 1997) . Their role in detoxifying air pollutant exposures has been investigated as potential modifiers in environmental health studies (Kelada, Eaton, Wang, Rothman, & Khoury, 2003) . For example, airborne polycyclic aromatic hydrocarbons (a component of particulate matter) have been associated with measures of genotoxicity of CYP1A1 and NAT2 genes (Kelada et al., 2003) . Futhermore, several studies have reported the role of specific variants in detoxification genes in association with congenital heart malformations including CYP1A1 and ABCB1 (Vecoli, Pulignani, & Andreassi, 2016) .
We view this investigation as exploratory even though some results showed sizable ORs (>4) and 95% CIs excluding 1. Such caution seems prudent owing to sample sizes being relatively small, numerous comparisons being made, and a paucity of previous studies to corroborate these findings. With regard to the latter, we are aware of only one previous study that has investigated spina bifida risk, gene variants, and air pollutants, with the pollutants being from indoor air pollution (exposure index score based on exposure active or passive smoking and coal combustion) or placental polycyclic aromatic hydrocarbons and 12 variants of AHR and CYP genes found that CYP1B1 modifies the effect of indoor air pollution and NTD risk. For mothers with the CYP1B1 (rs2855658) GG variant, exposure to indoor air pollution led to a dose response relationship for NTD risk, with ORs of 3.0 (95% CI: 1.6-5.7) and 8.1 (95% CI: 3.8-17) for medium and high levels of exposure, respectively. Although our study did not examine the CYP1B1 gene variants, we did find gene-environment interactions with several other CYP gene variants (CYP1A1, CYP1A2, CYP2B6, CYP2C8, CYP2C19, CYP2D6) (Wang et al., 2014) .
A previous study on smoking, which has similar constituents to air pollution, and NAT1 C1095A variant found an increased risk of spina bifida (p 5 .003) (Jensen, Hoess, Whitehead, & Mitchell, 2005) . Additional studies have examined the interaction between smoking and gene variants for their combined risk of gastroschisis and cleft palate (Jenkins et al., 2014; Torfs et al., 2006; Wu et al., 2012 ).
Although we know that maternal folic acid intake is associated with reduced risk of spina bifida, in general, the underlying biological mechanism has not been elucidated. Increased folic acid in the population through vitamin use and fortification of foods may have reduced spinia bifida, but the continued prevalence suggests that factors other than folic acid are involved with the etiology of spina bifida (Au, Ashley-Koch, & Northrup, 2010) , Several factors including low socioeconomic status and both advanced and young maternal age have been observed as risk factors for spina bifida in epidemiologic studies; however, several observations support genetic risk factors as well. Many studies have evaluated associations of neural tube defects with candidate genes known to code for proteins/enzymes in folate transport (e.g., SLC19A1), methylation (e.g., NAT1, NAT2), and oxidative stress (e.g., CYP26A1) (Au et al., 2010) . Given the mixed results, further research is warranted to examine further gene-environment interactions.
The results should be considered in context to some limitations of our study. The relatively small sample size for these types of analyses restricted the inference of our results. We performed numerous analyses and explored many potential effect modifiers without multiple comparisons made. These analyses are not meant to test a specific hypothesis, but rather serve as an initial investigation to generate hypotheses and begin the large amount of work needed to understand more complex pathways than previously examined.
| CON CL U S I ONS
Our study is the first examination of the interaction between these gene variants and air pollutant exposures with regard to spina bifida 
